 2 Biotechs Unveil Separate Fundings Totaling $325M

By Law360 Staff (March 20, 2024, 10:36 AM EDT) -- Life sciences companies Clasp Therapeutics and Cooley-advised Capstan Therapeutics, which develop treatments for a range of health conditions including cancer and autoimmune diseases, separately announced funding rounds Wednesday that together total $325 million. . . .

2 Biotechs Unveil Separate Fundings Totaling $325M

Clasp Therapeutics and Capstan Therapeutics, both focused on developing treatments for various health conditions like cancer and autoimmune diseases, announced separate funding rounds totaling $325 million.